Anil G.

Anil G. is a researcher at the German Cancer Research Center (DKFZ) in Heidelberg, Germany, specializing in neuro-oncology with a focus on meningiomas and radiotherapy approaches. His research primarily investigates how molecular profiling can guide treatment decisions for brain tumor patients.

His research interests center on neuro-oncology, with particular emphasis on molecular profiling of meningiomas, radiotherapy efficacy, and tumor recurrence prediction. His work bridges molecular biology with clinical applications to improve outcomes for brain tumor patients through precision medicine approaches.

His recent publications demonstrate a clear trend toward integrating molecular classification systems with traditional treatment approaches for meningiomas. His work examines how DNA methylation profiles and chromosomal losses can inform risk stratification and guide radiotherapy decisions for patients with varying grades of meningioma.

Anil G. collaborates extensively with clinical researchers at the University Hospital Heidelberg, particularly with Dr. Maximilian Deng and colleagues in the Department of Radiation Oncology. His research has contributed to understanding the relationship between molecular risk profiles, extent of surgical resection, and radiotherapy outcomes in meningioma patients.